Type II alveolar epithelial cell injury can be reduced by inhibiting the STAT3 pathway 47, indicating that IL-6 may participate in pulmonary fibrosis through alveolar epithelial cells. The gene discussed is STAT3; the disease is pulmonary fibrosis.